Protection from contamination by 211At, an enigmatic but promising alpha-particle-emitting radionuclide

[1]  Colin J. Martin,et al.  Radiation Safety and Accidental Radiation Exposures in Nuclear Medicine. , 2021, Seminars in nuclear medicine.

[2]  T. Watabe,et al.  α‐Emitting cancer therapy using 211At‐AAMT targeting LAT1 , 2020, Cancer science.

[3]  H. Fujii,et al.  Radiological protection and biological COVID-19 protection in the nuclear medicine department , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  M. Picchio,et al.  Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  Eva Forssell-Aronsson,et al.  Adsorption and volatility of free 211At and 125I-. , 2005, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[6]  T. Turkington,et al.  Measuring astatine-211 distributions with SPECT. , 1993, Physics in medicine and biology.

[7]  D. Wilbur.  Enigmatic astatine. , 2013, Nature chemistry.